Try our beta test site
99 studies found for:    Migraine AND 5-ht1 receptor
Show Display Options
Rank Status Study
1 Completed Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Condition: Migraine
Interventions: Drug: Rapimelt;   Drug: [11C]AZ10419369
2 Recruiting Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
Condition: Migraine Without Aura
Intervention: Other: PET scan with two different 5-HT receptor ligands
3 Completed Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
Conditions: Acute Migraine;   Migraine Headache;   Headache Disorders
Interventions: Drug: Zolmitriptan 5 mg Nasal Spray;   Drug: Eletriptan 40 mg tablet
4 Completed
Has Results
"Completeness of Response" Following Treatment With Treximet™ for Migraine
Condition: Migraine
Intervention: Drug: sumatriptan succinate 85 mg/naproxen sodium 500 mg (Treximet)
5 Completed Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache
Condition: Migraine
Intervention: Drug: sumatriptan and Treximet
6 Completed
Has Results
Ictal and Interictal Inflammatory Markers in Migraine
Condition: Migraine
Interventions: Drug: Treximet;   Drug: Placebo
7 Completed Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
Condition: Migraine Disorders
Interventions: Drug: Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap);   Drug: Triptan monotherapy
8 Unknown  Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: sumatriptan with naprosyn;   Drug: placebo
9 Completed Efficacy and Safety of BGG492 in the Treatment of Migraine
Condition: Migraine
Interventions: Drug: BGG492;   Drug: Sumatriptan;   Drug: Placebo
10 Completed Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
11 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
Conditions: Migraine Disorders;   Migraine
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
12 Completed Trial of Comprehensive Migraine Intervention
Condition: Migraine
Interventions: Drug: Naproxen;   Drug: Sumatriptan;   Behavioral: Migraine education;   Behavioral: Reenforcement of diagnosis;   Other: Typical care
13 Completed Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
Conditions: Migraine;   Migraine Disorders
Intervention: Drug: sumatriptan succinate/naproxen sodium
14 Completed
Has Results
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
Condition: Migraine
Interventions: Drug: Sumatriptan/Naproxen Sodium;   Drug: Naproxen Sodium
15 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
16 Completed
Has Results
Treximet in the Treatment of Chronic Migraine
Condition: Chronic Migraine
Interventions: Drug: Sumatriptan/Naproxen Sodium;   Drug: Naproxen Sodium
17 Completed A Study on the Usability of the Needle-Free Intraject® System in Adult Patients During Acute Migraine Attack
Condition: Migraine Headache
Intervention: Device: Intraject Sumatriptan
18 Completed
Has Results
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Condition: Migraine
Interventions: Device: Sumavel DosePro;   Drug: Sumatriptan
19 Completed
Has Results
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
Condition: Migraine
Interventions: Drug: Telcagepant potassium 150 mg;   Drug: Telcagepant potassium 300 mg;   Drug: Zolmitriptan 5 mg;   Drug: Placebo to telcagepant 150 mg;   Drug: Placebo to tecagepant 300 mg;   Drug: Placebo to zolmitriptan 5 mg;   Drug: Rescue medication
20 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Condition: Migraine Disorders
Interventions: Drug: Placebo;   Drug: Combination Product (sumatriptan succinate/naproxen sodium)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.